Products

All the Multilayer Flow Modulator (MFM®) devices share the unique capabilities that benefit both patients and medical staff:

  • Restoration of healthy laminar blood flow
  • Preservation of branch artery patency
  • Formation of organized stable thrombus
  • Rapid endothelialization along the vessel wall
  • Efficient minimally invasive implantation procedure

Aortic MFM®

Intended use

The Aortic MFM® is currently CE-mark approved for the endovascular treatment of patients with unruptured complex aortic aneurysms (aortic aneurysm involving at least one branch artery) with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency and improving perfusion
  • Endothelialization and integration, as the uncovered device allows endothelial tissue to be generated on the braided structure
  • The flared ends of the Aortic MFM® promote compliance with the aortic wall and ensure optimal sealing at both proximal and distal landing zones to avoid the risk of type I and III endoleaks
  • Conformability to complex aortic anatomy in challenging thoracoabdominal regions
  • Durability based on the with the multilayer braided design of the cobalt alloy wires
  • Low Profile, push-pull and kink-resistant reinforced delivery system

The Aortic MFM® is under clinical investigation for a total treatment of chronic type B aortic dissection. The MFM® restores the flow in the true lumen and ensures the thrombosis or the reduction of the false lumen while keeping branches patent.

Dr. Edward B. Diethrich talking about MFM®

Dimensions

Peripheral MFM®

Intended use

The Peripheral MFM® is currently CE-mark approved for endovascular treatment of patients with unruptured peripheral artery aneurysms (iliac, visceral, popliteal and subclavian arteries), with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency
  • Endothelialization and integration, as the uncovered device allows endothelial tissue to be generated on the braided structure

  • Device lengths and conformability suitable for challenging popliteal regions

  • Durability based on the multilayer braided design of the cobalt alloy wires

 

Dimensions

Intracranial MFM®

Intended use

The Intracranial MFM® with the associated microcatheter system is currently CE-mark approved for endovascular treatment of patients with unruptured intracranial aneurysms with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency
  • Endothelialization and integration as the uncovered device allows endothelial tissue to be generated on the braided structure
  • Unique structure and flexibility allowing optimal navigation